Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
about
An integrative view on sex differences in brain tumorsSexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in malesSex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.A framework for detecting and characterizing genetic background-dependent imprinting effects.Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patientsThe cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesisGenetically engineered mouse models in cancer researchPediatric gliomas as neurodevelopmental disordersChromosome substitution strains: gene discovery, functional analysis, and systems studies.EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.Contextual signaling in cancer.Exploring the genetic basis for clinical variation in neurofibromatosis type 1.The impact of the genetic background in the Noonan syndrome phenotype induced by K-Ras(V14I).Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1.Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis.
P2860
Q26829861-886BE5B9-9C3E-4012-8DDE-CF5C171EEB70Q34117529-61F3147F-7656-434B-AB69-575A208D4960Q34231047-DAA600A3-163C-4A8D-A390-7C45940E1EC6Q34287133-63042228-D325-4A2B-A1B1-627FCC459137Q34350807-11AC08DB-EE3D-4896-B5C9-A3921843B713Q34544321-1B3F6871-4D38-4D3B-8D68-68BBD3F6AB10Q34859935-52274D19-DCB7-4490-8F24-89AC5F7A858AQ34988075-1B5A2812-7097-4546-AE66-0F4C7C2E3CEDQ35696405-085145A5-7093-47FD-AB44-B27C0ABB2C74Q35823362-AC8EDA3E-5B91-4D58-BAF9-F4A684628E91Q36290277-1A907B0E-20C3-4267-B6E3-73BD65031625Q36497718-7B669C0E-73B7-4F73-8998-555CDFBD83DDQ36803476-FFFE3D8E-6D78-44AF-B315-426D4B23BA2AQ37567595-BB1D0EF5-9630-4F97-83D5-348657A0415CQ37582297-6B152A00-0D59-4F74-9E40-9C06B9017220Q38740814-53F47F33-B928-4FAE-A01D-D3A8D456A9E0Q38857220-B9033DEB-E9C8-48CA-9378-343124120C81Q41172460-EC876C9F-161D-4F4A-9456-2804C9F71E4CQ41531872-97DAD52A-2B31-43E4-A608-8771E639976CQ52899965-5E227D64-2112-4C91-9DBB-1C8DE416EDF1Q55464276-EA348ED8-A46B-4EC5-B1E6-2728099FFB20
P2860
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chr 19
@nl
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
@en
type
label
Chr 19
@nl
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
@en
prefLabel
Chr 19
@nl
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
@en
P2093
P2860
P1433
P1476
Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.
@en
P2093
Erika Truffer
Jessica C Walrath
Karlyne M Reilly
Kristi Fox
Octavio A Quiñones
W Gregory Alvord
P2860
P2888
P304
P356
10.1007/S00335-009-9179-4
P577
2009-04-04T00:00:00Z